|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129.24 CHF | +0.67% |
|
+4.68% | +17.57% |
| 06:51am | Novartis Says Chronic Skin Condition Drug Shows Positive Results in Trial | DJ |
| 06:47am | Novartis Reports Positive Results from Phase 3 Trial of Chronic Inducible Urticaria Oral Drug | MT |
Chart calendar Novartis AG
Upcoming events on Novartis AG
| 02/03/2026 | TD Cowen Health Care Conference | Add to your calendar Google Apple ICS format |
| 03/03/2026 | UBS European Healthcare Conference | Add to your calendar Google Apple ICS format |
| 06/03/2026 | Annual General Meeting | Add to your calendar Google Apple ICS format |
| 09/03/2026 | Barclays Global Healthcare Conference | Add to your calendar Google Apple ICS format |
| 09/03/2026 | For final dividend | Add to your calendar Google Apple ICS format |
| 23/03/2026 | BNP Paribas Exane Healthcare Conference | Add to your calendar Google Apple ICS format |
| 24/03/2026 | Goldman Sachs Innovation Clinic Conference | Add to your calendar Google Apple ICS format |
| 27/04/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 20/07/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 26/10/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 02/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 26/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 19/07/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 25/10/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Novartis AG
| 04/02/2026 | Q4 2025 Earnings Call |
| 04/02/2026 | Q4 2025 Earnings Release |
| 12/01/2026 | J.P. Morgan Healthcare Conference |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-08 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-15 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-08-27 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PD5-10 |
| 10/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-04-17 |
| 10/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-10-27 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #LBA-2 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #4981 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #4978 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #5549 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #906 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #910 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #844 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #3198 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #670 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #724 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #1997 |
Past dividends on Novartis AG
| 10/03/2025 | Annual 3.5 CHF |
| 06/03/2024 | Annual 3.3 CHF |
| 08/03/2023 | Annual 3.2 CHF |
| 07/03/2022 | Annual 3.1 CHF |
| 03/03/2021 | Annual 3 CHF |
| 02/03/2020 | Annual 2.95 CHF |
| 03/03/2019 | Annual 2.85 CHF |
| 05/03/2018 | Annual 2.8 CHF |
| 01/03/2017 | Annual 2.75 CHF |
| 24/02/2016 | Annual 2.7 CHF |
| 02/03/2015 | 2.6 CHF |
| 26/02/2014 | Annual 2.45 CHF |
| 25/02/2013 | Annual 2.3 CHF |
| 26/02/2012 | Annual 2.25 CHF |
| 23/02/2011 | Annual 2.2 CHF |
| 01/03/2010 | Annual 2.1 CHF |
| 26/02/2009 | Annual 2 CHF |
| 28/02/2008 | Annual 1.6 CHF |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 660 46 810 -0.32% | 51 722 50 407 2.61% | 56 674 55 618 1.9% | 57 354 | 60 068 | 63 706 |
|
EBITDA Million USD | Released Forecast Spread | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 415 23 681 -1.12% | 23 333 | 25 129 | 27 076 |
|
EBIT Million USD | Released Forecast Spread | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 889 21 846 0.19% | 21 860 | 23 210 | 25 274 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 16 352 17 360 -5.81% | 17 696 | 19 181 | 21 922 |
|
Net income Million USD | Released Forecast Spread | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 13 967 14 570 -4.14% | 14 486 | 15 962 | 17 844 |
|
EPS USD | Released Forecast Spread | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,21 7,16 0.7% | 7,56 | 8,42 | 9,78 |
| Announcement Date | 31/01/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 872 12 319 4.49% | 13 172 12 666 4% | 13 558 12 823 5.73% | 13 620 13 116 3.85% | 14 836 14 136 4.95% | 14 358 13 866 3.55% | 13 860 14 111 -1.78% | 13 647 | 14 283 | 14 575 | 14 775 | 13 820 | 14 400 | 14 635 | 14 755 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | 5 338 4 861 9.81% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | 4 953 4 667 6.12% | 5 145 4 892 5.16% | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 929 5 010 -1.62% | 5 374 | 5 611 | 5 610 | 5 243 | 5 370 | 5 575 | 5 595 | 5 555 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 841 3 896 -1.41% | 3 385 4 028 -15.96% | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | |||||||||||
|
Net income Million USD | Released Forecast Spread | 3 246 2 858 13.59% | 3 189 3 197 -0.25% | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 404 2 414 -0.4% | 3 217 | 3 523 | 3 500 | 3 345 | ||||
|
EPS USD | Released Forecast Spread | 1,60 1,40 14.13% | 1,58 1,48 7.03% | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,26 1,26 0.23% | 1,68 | 1,84 | 1,83 | 1,76 | ||||
| Announcement Date | 18/07/24 | 29/10/24 | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | 04/02/26 | - | - | - | - | - | - | - | - |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 22/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 23/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 23/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Novartis AG
| Today | Q4 2025 Earnings Release (Projected) | |
| Today | Q4 2025 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
- Calendar Novartis AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















